Aggrecan Residues 89-106 Peptide

Human aggrecan peptide corresponding to residues 89-106 with an N-terminal cysteine.

Aggrecan epitope mapping, antibody-blocking controls and cartilage-matrix research.

This sequence-defined peptide is intended for research use. Confirm solubility, storage, concentration and assay controls for the intended experimental system. The supplied material is not intended for diagnostic or therapeutic use.